Cargando…
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
BACKGROUND: In December 2019, the coronavirus disease 2019 (COVID-19) outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited. OBJECTIVE: We sought to evaluate the severity on admission, complications, treatment, and outcomes of pati...
Autores principales: | Li, Xiaochen, Xu, Shuyun, Yu, Muqing, Wang, Ke, Tao, Yu, Zhou, Ying, Shi, Jing, Zhou, Min, Wu, Bo, Yang, Zhenyu, Zhang, Cong, Yue, Junqing, Zhang, Zhiguo, Renz, Harald, Liu, Xiansheng, Xie, Jungang, Xie, Min, Zhao, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152876/ https://www.ncbi.nlm.nih.gov/pubmed/32294485 http://dx.doi.org/10.1016/j.jaci.2020.04.006 |
Ejemplares similares
-
The immunologic status of newborns born to SARS-CoV-2–infected mothers in Wuhan, China
por: Liu, Pin, et al.
Publicado: (2020) -
Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study
por: Wang, Fang, et al.
Publicado: (2020) -
15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study
por: Wang, Ke, et al.
Publicado: (2020) -
Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran
por: REZAEI, FATEMEH, et al.
Publicado: (2022) -
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
por: Cao, Yang, et al.
Publicado: (2020)